BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6543506)

  • 1. [Hypertension, coronary disease and calcium antagonists].
    Dal Palù C
    Cardiologia; 1984; 29(9-10):433-4. PubMed ID: 6543506
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium antagonists in cardiology].
    Tullio D; Valerio A; D'Agostino F
    Clin Ter; 1983 Jan; 104(1):27-51. PubMed ID: 6337771
    [No Abstract]   [Full Text] [Related]  

  • 3. [24-hour protection and control: a new era of calcium antagonists. Amlodipine provides 24 hours of efficacy and safety].
    Med Clin (Barc); 1992 Feb; 98(8):suppl 2 p.. PubMed ID: 1532845
    [No Abstract]   [Full Text] [Related]  

  • 4. [New approach to the development of Ca antagonists].
    Baba A; Arita M; Masuyama Y
    Nihon Rinsho; 1989 Aug; 47(8):1788-93. PubMed ID: 2585742
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium antagonists in coronary disease and hypertension.
    Palmer CR; Day NE
    Circulation; 1996 Sep; 94(5):1142-3. PubMed ID: 8790065
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockade in heart failure.
    Guazzi MD; Bartorelli A; Pepi M; Guazzi M
    Cardiologia; 1989 Feb; 34(2):117-25. PubMed ID: 2660989
    [No Abstract]   [Full Text] [Related]  

  • 8. How safe are calcium antagonists in hypertension and coronary heart disease?
    Mancia G; van Zwieten PA
    J Hypertens; 1996 Jan; 14(1):13-7. PubMed ID: 12013485
    [No Abstract]   [Full Text] [Related]  

  • 9. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.
    Tijssen JG; Hugenholtz PG
    Eur Heart J; 1996 Aug; 17(8):1152-7. PubMed ID: 8869855
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanisms of the protective action of the calcium antagonists corynphar and verapamil in myocardial ischemia and subsequent reperfusion].
    Litvitskiĭ PF
    Farmakol Toksikol; 1982; 45(2):65-70. PubMed ID: 7075755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists in the treatment of patients with diseases of the cardiovascular system (review of foreign literature)].
    Smolenskii VS; Abinder AA; Kamenker SM
    Klin Med (Mosk); 1985 Feb; 63(2):17-27. PubMed ID: 3887022
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardioprotection quo vadis? The role of nifedipine. 5-6 November 1982, Amsterdam, The Netherlands.
    Eur Heart J; 1983 May; 4 Suppl C():1-135. PubMed ID: 6617691
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between predicted theoretical mechanistic biochemistry (TMB) data and therapeutic effects in the management of vascular disorders with calcium channel blockers.
    Akintonwa DA; Odigwe CO
    Med Hypotheses; 2000 Jun; 54(6):944-7. PubMed ID: 10867744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New advances in the clinical uses of calcium antagonists].
    Huang SB
    Zhonghua Yi Xue Za Zhi; 1989 Feb; 69(2):115-7. PubMed ID: 2670103
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium entry blockers: usefulness in ischemia and hypertensive heart disease. September 23 to 28, 1988, Cannes, France. Proceedings.
    Circulation; 1989 Dec; 80(6 Suppl):IV1-188. PubMed ID: 2598452
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controversy over calcium antagonists: is there a rationally differentiating therapy?].
    Lüscher TF; Wenzel RR; Noll G
    Dtsch Med Wochenschr; 1996 Apr; 121(16):532-8. PubMed ID: 8612465
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological properties and use of calcium channel blockers].
    Kostowski W; Obersztyn M
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1701-5. PubMed ID: 6395120
    [No Abstract]   [Full Text] [Related]  

  • 19. The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy).
    Schulz J; Schmidt J; Rück W
    Curr Med Res Opin; 1996; 13(7):397-408. PubMed ID: 8862939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
    Sierra C; Coca A
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1055-62. PubMed ID: 18793108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.